The 9th edition of the University of Porto-backed program BIP Proof distinguished six innovative projects, half of which hail from #i3S: AngioHeal Therapeutics, PRECISE-O, and SENSEgraft. Each of these projects was awarded 10 thousand euros.
📰👀👇
#i3Sresearch #i3Sinnovation #UPorto

#i3S researchers Mónica Sousa and Ana Rita Costa recently published a paper in the journal 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 𝘈𝘥𝘷𝘢𝘯𝘤𝘦𝘴, in which they outline the workings of new mechanisms that help explain how neurons build and maintain their inner architecture.
📰👀👇
#i3Sresearch #i3Sinnovation #i3Spapers #neurobiology

ADVANCE-TB, a COST-funded initiative, recently published a paper analyzing innovative approaches to treating tuberculosis. #i3S researcher Tânia Silva is the paper's first author and vice-Chair of project ADVANCE-TB.
📰👀👇
#i3Sresearch #i3Sinnovation #COSTActions #TB

While we missed World #Cancer Research Day, we couldn't let it go unnoticed, so we're sharing this interview given by #i3S researcher Jorge Lima in the scope of the launch of a new pediatric cancer research award.
📺👀👇
#i3Snews #i3Sresearch #cancerresearch

The #Longevity Summit took place late last week at Alfândega do Porto, where experts discussed the state-of-the-art and future of #aging. #i3S researcher José Pedro Castro was among the invited speakers and discussed the important role played by controlled inflammation.
#i3Snews #i3Sresearch

#i3S spin-offs secure over 1.3M€ in EU funding!
Fetalix, GOTECH Antimicrobial and SecretomeDx were selected to take part in the 1st edition of EIC Pre-Accelerator, a program promoted by the European Innovation Council.
Learn ➕ about each one and their purpose 📰👀👇
#i3Sprojects #i3Sresearch #i3Snews